KS Biomedix drops OA compound

KS Biomedix (LSE:KSB) dropped development of its KSB301 after the compound did not

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE